Undiagnosed Diseases
7
3
4
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 85/100
14.3%
1 terminated out of 7 trials
0.0%
-86.6% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Clinical Trials (7)
Genetic Analysis of Uncommon Disease Presentations in Non-US Populations
Human Biospecimen Procurement Protocol: Biorepository to Support Translational Research to Identify Disease Mechanism(s)
Caregiving Networks Across Disease Context and the Life Course
The Mayo Clinic Rare and Undiagnosed Disease Hackathon
Research for Individualized Therapeutics in Rare Genetic Disease
Project 1: ACHIEVE- HTN
A Pivotal Clinical Investigation Confirming the Safety and Accuracy of the Glyconics-DS in Assessment of Glycated Nail Keratin in Individuals With Unknown Diabetes Status and Performance Evaluation of the Glyconics SW Package